ABVC BioPharma Inc

NASDAQ:ABVC   3:59:54 PM EDT
2.61
+0.08 (+3.16%)
Products

ABVC Biopharma Inc Restructures Joint Venture To Expand Access To Early-Stage Research

Published: 10/12/2021 12:57 GMT
ABVC BioPharma Inc (ABVC) - Abvc Biopharma Restructures Joint Venture to Expand Access to Early-stage Research.
Abvc Biopharma Inc - Abvc Will Retain Equity Ownership in Biolite Japan at 49%.
Abvc Biopharma Inc - Lucidam Will Retain Equity Ownership in Biolite Japan at 51%.
Abvc Biopharma Inc - Execution of a Joint Venture Agreement With Lucidam, a Private Investment Firm Based in Tokyo.
Abvc Biopharma Inc - Biolite Japan Will Transfer Rights of Most Promising Research to Abvc for Further Clinical Development.
Abvc Biopharma Inc - Biolite Japan Will Seek Potential Licensing Partners for Abvc's Current Pipeline of Drug Products and Medical Devices.